4th Annual Cardiovascular Conference: Advances in Cardiovascular Disease - from Prevention to Intervention


 

GLP-1 Agonists: A Review of Within Class Differences for CVD Risk Reduction

April 20, 2021

2 Comments
Login to view comments. Click here to Login
Session 3